0000950103-16-015433.txt : 20160808 0000950103-16-015433.hdr.sgml : 20160808 20160808151422 ACCESSION NUMBER: 0000950103-16-015433 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20160808 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20160808 DATE AS OF CHANGE: 20160808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Shire plc CENTRAL INDEX KEY: 0000936402 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29630 FILM NUMBER: 161813878 BUSINESS ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 ZIP: RG24 8EP BUSINESS PHONE: 441256894000 MAIL ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 ZIP: RG24 8EP FORMER COMPANY: FORMER CONFORMED NAME: Shire Ltd. DATE OF NAME CHANGE: 20080523 FORMER COMPANY: FORMER CONFORMED NAME: Shire plc DATE OF NAME CHANGE: 20051125 FORMER COMPANY: FORMER CONFORMED NAME: SHIRE PHARMACEUTICALS GROUP PLC DATE OF NAME CHANGE: 19980302 8-K 1 dp67838_8k.htm FORM 8-K

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 8, 2016

 

SHIRE PLC

(Exact name of registrant as specified in its charter)

 

Jersey, Channel Islands 0-29630 98-0601486
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)

 

5 Riverwalk, Citywest Business Campus, Dublin 

24, Republic of Ireland 

(Address of principal executive offices)

 

 

Registrant’s telephone number, including area code:        +353 1 429 7700

 

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Item 8.01.Other Events

 

Shire plc has issued the press release attached hereto as Exhibit 99.1 which is incorporated by reference herein.

 

Item 9.01.Financial Statements and Exhibits

 

(d)Exhibits. The following exhibit is furnished herewith:

 

99.1Press Release dated August 8, 2016

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Shire plc
       
  By:  /s/ W R Mordan
    Name:  Bill Mordan
    Title: Company Secretary

Date: August 8, 2016

 

 

EXHIBIT INDEX

 

Exhibit No.

 

Description

   
99.1   Press Release dated August 8, 2016

 

 

 

 

EX-99.1 2 dp67838_ex9901.htm EXHIBIT 99.1

 

Exhibit 99.1

 

Press Release

www.shire.com

 

 

 

Director/PDMR Shareholding

 

August 8, 2016 – Shire plc (LSE: SHP, NASDAQ: SHPG)

 

Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1. Details of the person discharging managerial responsibilities / person closely associated them
a) Name Kim Stratton
2. Reason for the notification
a) Position / status Head of International Commercial
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc Ordinary Shares of 5 pence each (“Ordinary Shares”)

 

Identification code ISIN: JE00B2QKY057
b) Nature of the transaction Acceptance of Restricted Stock Units in respect of notional Ordinary Shares awarded under the Shire Long Term Incentive Plan 2015 in recognition of promotion to Executive Committee membership. Subject to continued service, 50% of the award will vest on August 5, 2018, and 50% will vest on August 5, 2019.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 6,149
d)

Aggregated information

- Aggregated volume

- Price

N/A (single transaction)

 

e) Date of the transaction August 5, 2016
f) Place of the transaction Outside a trading venue

 

 

1. Details of the person discharging managerial responsibilities / person closely associated them
a) Name Perry Sternberg
2. Reason for the notification
a) Position / status Head of US Commercial
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc American Depositary Shares (“ADSs”)

 

Identification code ISIN: US82481R1068
b) Nature of the transaction Acceptance of Restricted Stock Units in respect of notional ADSs awarded under the Shire Long Term Incentive Plan 2015 in recognition of promotion to Executive Committee membership. Subject to continued service, 50% of the award will vest on August 5, 2018, and 50% will vest on August 5, 2019.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 1,998
d)

Aggregated information

- Aggregated volume

- Price

N/A (single transaction)

 

e) Date of the transaction August 5, 2016
f) Place of the transaction Outside a trading venue

 

For further information please contact:

 

Investor Relations    
Sarah Elton-Farr seltonfarr@shire.com +44 1256 894157

 

 

NOTES TO EDITORS

 

Shire is the leading global biotechnology company focused on serving people with rare diseases and other highly specialized conditions. We strive to develop best-in-class products, many of which are available in more than 100 countries across core therapeutic areas including Hematology, Immunology, Neuroscience, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; a growing franchise in Oncology; and an emerging, innovative pipeline in Ophthalmics.

 

Our employees come to work every day with a shared mission: to develop and deliver breakthrough therapies for the hundreds of millions of people in the world affected by rare diseases and other high-need conditions, and who lack effective therapies to live their lives to the fullest.

 

www.shire.com

 

 

GRAPHIC 3 image_001.jpg GRAPHIC begin 644 image_001.jpg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end